Analysis of 31 CFTR mutations by polymerase chain reaction/oligonucleotide ligation assay in a pilot screening of 4476 newborns for cystic fibrosis

Objectives Molecular biological testing for genetic diseases has grown rapidly, but speed, accuracy, specificity, sensitivity, throughput, and cost become more important as large scale screening is considered. This is a pilot study of an assay for the simultaneous detection of up to 31 cystic fibrosis mutations in a multicentre population based screening of 4476 Italian newborns. Methods The assay is a polymerase chain reaction, followed by an oligonucleotide ligation assay (PCR/OLA) and finally a sequence coded separation. It allows the detection of up to 31 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Guthrie spots were used as a source of template DNA. Results 144 carriers were detected during the analysis of 4476 samples, which translates into a carrier frequency of 1/31.1. Forty two carriers were detected from 1341 samples in Pavia (1/31.9), 53 from 1574 in Turin (1/29.7), and 49 from 1561 in San Giovanni Rotondo (1/31.8). Fifteen different mutations were detected, the most common being ΔF508 (0.625). Other common mutations included G542X (16 of 144), which was particularly common in southern Italy (14 of 49), N1303K (8 of 144), and R117H (8 of 144), detected only in the northern centres. Conclusions PCR/OLA is a robust, accurate, user friendly method for cystic fibrosis screening of newborns using blood spots in a semiautomated way at a low cost per mutation (0.8 Euro).

[1]  John C. Hershey,et al.  Carrier Screening for Cystic Fibrosis , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[2]  A. Metspalu,et al.  Neonatal screening for the cystic fibrosis main mutation ΔF508 in Estonia , 1998 .

[3]  S. Loader,et al.  Carrier screening for cystic fibrosis: test acceptance and one year follow-up. , 1997, American journal of medical genetics.

[4]  A. Piazza,et al.  Genetic history of cystic fibrosis mutations in Italy. I. Regional distribution , 1997, Annals of human genetics.

[5]  M. Kosorok,et al.  Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods. , 1997, Pediatrics.

[6]  B. Housset,et al.  CFTR Gene Mutations in Adults with Disseminated Bronchiectasis , 1997, European journal of human genetics : EJHG.

[7]  C. Castellani,et al.  Newborn screening strategy for cystic fibrosis: a field study in an area with high allelic heterogeneity , 1997, Acta paediatrica.

[8]  R. Cantor,et al.  PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population. , 1997, American journal of human genetics.

[9]  G. Turner,et al.  Cystic fibrosis carrier screening in two New South Wales country towns. , 1996, The Medical journal of Australia.

[10]  Arie,et al.  Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. , 1995, The New England journal of medicine.

[11]  P. Pignatti,et al.  Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis. , 1995, Human molecular genetics.

[12]  D. Brock Carrier screening for cystic fibrosis , 1994, Prenatal diagnosis.

[13]  E. Winn-Deen,et al.  High-density multiplex detection of nucleic acid sequences: oligonucleotide ligation assay and sequence-coded separation. , 1994, Nucleic acids research.

[14]  A. Metspalu,et al.  Neonatal screening for the cystic fibrosis main mutation delta F508 in Estonia. , 1998, Journal of medical screening.

[15]  S. Loader,et al.  Cystic fibrosis carrier population screening: a review. , 1997, Genetic testing.

[16]  E. Winn-Deen,et al.  Introduction to PCR/OLA/SCS, a multiplex DNA test, and its application to cystic fibrosis. , 1997, Genetic testing.

[17]  X. Estivill,et al.  Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium. , 1997, Human mutation.

[18]  X. Estivill,et al.  Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations , 1997 .